Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]
Jones G, Panova E, Day R. Drug Des Devel Ther. 2017;11:3077–3081.On page 3078, Table 1, Abbreviation list, expansion for FBX was incorrectly listed as feboxustat, the correct spelling is febuxostat.Read the original article
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-12-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | https://www.dovepress.com/corrigendum-for-the-management-of-gout-role-of-combinat-peer-reviewed-article-DDDT |